Referenser
- Brooks P M. Side effects of non-steroidal antiinflammatory drugs. Med J Aust 1988; 148: 248–51
- Buchanan W W., Kean W F. Current non-steroidal antiinflammatory drug therapy in rheumatoid arthritis, with emphasis on use in the elderly. Nonsteroidal Anti-inflammatory Compounds, A J. Lewis, D E. Furst. Marcel Dekker, New York 1987; 9–29
- Fries J F. The ARAMIS (American Rheumatism Association Medical Information System) Post-marketing Surveillance Program. Drug Info J 1985; 19: 257–62
- Fries J F., McShane D J. ARAMIS (American Rheumatism Association Medical Information System): A prototypical national chronic-disease data bank. West J Med 1986; 145: 798–804
- Fries J F., Miller S R., Spitz P W., Williams C A., Hubert H B., Bloch D A. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterol 1989; 96: 647–55
- Fries J F., Williams C A., Bloch D A., Michel B A. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213–22
- Mitchell D M., Spitz P W., Young D Y., Bloch D A., McShane D J., Fries J. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29: 706–14
- Pincus T, Callahan L F. Taking mortality in rheumatoid arthritis seriously – predictive markers, socioeconomic status and co-morbidity. J Rheumatol 1986; 14: 841–5
- Fries J F., Spitz P W., Williams C A., Bloch D A., Singh G, Hubert H B. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990; 33: 121–30
- Fries J F., Williams C A., Bloch D A. The relative toxicity of non-steroidal anti-inflammatory drugs. Arthritis Rheum 1991; 34: 1353–60
- Carson J L., Strom B L., Morse M L., West S L., Soper K A., Stolley P D., et al. The relative gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs. Arch Intern Med 1987; 147: 1054–9
- Griffin M R., Piper J M., Daugherty J R., Snowden M, Ray W A. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257–63
- Larkai E N., Smith J L., Lidsky M D. Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic non-steroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153–8
- Metropolitan Life Insurance Co. Anti-arthritis medication usage: United States 1991. Statistical Bulletin. July-September, 1992
- Roth S J., Bennet R E. Non-steroidal anti-inflammatory drug gastropathy: recognition and response. Arch Intern Med 1987; 147: 2093–100
- Fries J F., Williams C A., Ramey D R., Bloch D A. The relative toxicity of disease modifying anti-rheumatic drugs (DMARDs). Arthritis Rheum 1993; 36: 297–306
- Fries J F. Re-evaluating the therapeutic approach to rheumatoid arthritis: the “sawtooth” strategy. J Rheumatol 1990; 17(Suppl 22)12–5
- Pincus T. The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis. Semin Arthritis Rheum 1992; 21(Suppl 3)2–15
- Wilske K R., Healey L A. Remodelling the pyramid: a concept whose time has come. J Rheumatol 1989; 15: 565–7